남용 약물 검사 시장 규모, 점유율, 성장 분석 : 제품 유형별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)

Global Drugs Of Abuse Testing Market size was valued at USD 6.7 billion in 2023 and is poised to grow from USD 6.8 billion in 2024 to USD 7.66 billion by 2032, growing at a CAGR of 1.5% during the forecast period (2025-2032).

The global drugs of abuse testing market is experiencing significant growth driven by an increasing emphasis on employment medical screenings and a rising incidence of substance use. This trend is further fueled by heightened awareness of substance use disorders and the urgent need for reliable testing methods amid alarming rates of drug-related fatalities. Innovations in testing technology, such as point-of-care and rapid testing (POCT), are on the rise, offering timely and accurate results for roadside and workplace screenings. Additionally, non-invasive testing methods using saliva, sweat, and hair are gaining traction for their convenience and lower contamination risks. However, challenges like limited awareness in developing regions, high device costs, and stringent regulations may hinder market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drugs Of Abuse Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drugs Of Abuse Testing Market Segments Analysis

Global Drugs Of Abuse Testing Market is segmented by Product, Sample Type, Application, End User and region. Based on Product, the market is segmented into Consumables, Equipment, Rapid Testing Devices and Services. Based on Sample Type, the market is segmented into Saliva, Urine, Hair, Breath, Blood and Sweat. Based on Application, the market is segmented into Medical Screening, Monitoring Pain Management, Forensic & Legal Information, Employment Drug Testing and Sports & Athletics Testing. Based on End User, the market is segmented into Hospital, Forensic Labs, Diagnostic Centres and Speciality Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drugs Of Abuse Testing Market

The Global Drugs of Abuse Testing market is primarily driven by advancements in technology that have led to the creation of more precise and reliable testing instruments. As living standards continue to improve, there is a growing emphasis on drug abuse testing among adults, which is being actively promoted by both governmental and private sectors. This initiative aims to address and mitigate issues related to drug misuse, contributing to the overall expansion of the market. The increasing awareness of the importance of drug testing, coupled with enhanced testing methodologies, plays a crucial role in fostering market growth.

Restraints in the Global Drugs Of Abuse Testing Market

The global drugs of abuse testing market faces significant challenges related to cost and affordability, which hinder its widespread adoption. Many smaller companies and healthcare providers find comprehensive testing programs prohibitively expensive, limiting growth opportunities within the industry. Additionally, the market grapples with issues surrounding adulteration and evasion tactics, as individuals often resort to methods such as using synthetic urine or masking agents to circumvent testing protocols. These practices undermine the efficacy of screening methods and pose further obstacles to maintaining the integrity and reliability of drug testing processes within the market.

Market Trends of the Global Drugs Of Abuse Testing Market

The Global Drugs Of Abuse Testing market is experiencing a significant shift towards non-invasive testing techniques, propelled by the growing demand for simplified, safe, and privacy-friendly collection methods. Sample types such as sweat, hair, and saliva are increasingly favored over traditional invasive procedures like blood or urine, as they offer enhanced convenience and reduced contamination risks. This trend is further amplified by the ability of non-invasive methods to provide longer detection windows, making them ideal for applications in roadside testing, rehabilitation centers, and workplace settings. As these technologies continue to advance, they are set to reshape the landscape of drugs of abuse testing.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Drugs Of Abuse Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
• Equipment
• Rapid Testing Devices
• Services

Global Drugs Of Abuse Testing Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Saliva
• Urine
• Hair
• Breath
• Blood
• Sweat

Global Drugs Of Abuse Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Medical Screening
• Monitoring Pain Management
• Forensic & Legal Information
• Employment Drug Testing
• Sports & Athletics Testing

Global Drugs Of Abuse Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital
• Forensic Labs
• Diagnostic Centres
• Speciality Clinics

Global Drugs Of Abuse Testing Market Size & CAGR (2025-2032)

• North America (Product, Sample Type, Application, End User)
  • US
  • Canada
• Europe (Product, Sample Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Sample Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Sample Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Sample Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024

Key Company Profiles

• Quest Diagnostics Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Express Diagnostics International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Blue Origin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinical Reference Laboratory, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordant Health Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations